Anti-angiogenesis therapies: their potential in cancer management
about
Current targeted therapies in the treatment of advanced colorectal cancer: a reviewNeuropilins: expression and roles in the epitheliumThe role of lymphatics in cancer as assessed by near-infrared fluorescence imagingSolution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexesCancer biology in diabetes.Radioembolization of hepatic tumorsSuppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody.Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.Current and emerging therapies for advanced adrenocortical carcinoma.Lung cancer cellular apoptosis induced by recombinant human endostatin gold nanoshell-mediated near-infrared thermal therapy.Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patientsDiabetic angiopathy and angiogenic defects.Antiangiogenic effects of oridonin.The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.Unique biology of gliomas: challenges and opportunities.Effect of thalidomide on the proliferation of hepatoma cells assessed by osteopontin levels in nude mice.Angiogenesis and breast cancer.Neuropilin-1 as Therapeutic Target for Malignant Melanoma.Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.1-aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 tyrosine kinase inhibitors: synthesis, biological evaluation, and molecular modelling studies.RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cellsSorafenib Improves Survival in Metastatic Hepatocellular Carcinoma: A Case Report.
P2860
Q26740067-6436E70A-4D11-4023-8EDA-99EB3D41C31DQ26998786-1EF805E7-31FF-4F63-B95B-4DA0B9F297CDQ27001155-C263ACE2-FAAC-443E-A262-376577869919Q27679870-CA745002-9076-43B6-8407-00B1D59D07CDQ33608038-B20806AC-86CF-4A50-B5EB-6177AAB1AA08Q33820777-70237EA5-6890-4261-AE23-816D7CF87A21Q35092548-E9699A34-5331-45BA-A113-E8F0D4E5DF92Q35233993-E9E00BAC-EE73-47D8-9514-9E8C147862E4Q35584305-F7D6D1FD-8198-468C-9E50-D834D61331C1Q35756373-DDE33B3A-B99F-4FCF-850F-525BC55F791CQ35879398-724552EA-9468-41A3-A7FF-2796BE5BFEEFQ36301365-FDA103DF-C87C-4BD1-BC1F-3B152C35C431Q36334914-AB701D42-68B2-4CDB-807E-3D130EE1093AQ36612613-E323B064-6D6A-40DF-A0A6-63224A0E69DFQ36626214-83D8EB01-D3A6-4D7A-B508-7B13E49111AEQ36900631-65E5CC88-F435-4BAD-9100-DF92F6CC35A5Q37800804-952E0EB9-7BE1-4260-9932-30748671804DQ38532037-B9540224-311E-4D4E-888F-CD8F920A5AC3Q41135124-8AF24C40-6506-4E35-ADA7-F5F9FF65C271Q41851477-C2F4274F-F877-420D-838C-2B09BD77D6DFQ41880317-2F95D1C7-2805-4909-80FE-5A204A04BF23Q47126334-02398034-70BA-4454-B1F4-8A78DA95DC8B
P2860
Anti-angiogenesis therapies: their potential in cancer management
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Anti-angiogenesis therapies: their potential in cancer management
@ast
Anti-angiogenesis therapies: their potential in cancer management
@en
type
label
Anti-angiogenesis therapies: their potential in cancer management
@ast
Anti-angiogenesis therapies: their potential in cancer management
@en
prefLabel
Anti-angiogenesis therapies: their potential in cancer management
@ast
Anti-angiogenesis therapies: their potential in cancer management
@en
P2093
P2860
P1476
Anti-angiogenesis therapies: their potential in cancer management
@en
P2093
Andrew Eichholz
Andrew M Gaya
Shairoz Merchant
P2860
P407
P577
2010-06-24T00:00:00Z